Securities code: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) securities abbreviation: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) Announcement No.: 2022025 Tibet Duo Rui Pharmaceutical Co.Ltd(301075)
Announcement on the appointment of deputy general manager
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) (hereinafter referred to as “the company” or ” Tibet Duo Rui Pharmaceutical Co.Ltd(301075) “) held the 11th meeting of the first board of directors on March 23, 2022, deliberated and adopted the proposal on the appointment of deputy general manager.
According to the nomination of the general manager of the company, the board of directors of the company agreed to appoint Mr. Ao Bo as the deputy general manager of the company. The term of office starts from the date of deliberation and approval of the board of directors to the date of expiration of the term of office of the first board of directors. Mr. Aobo’s resume is attached.
The independent directors of the company expressed their independent opinions on this matter.
As of the date of this announcement, Mr. Aobo does not hold shares of the company, has no relationship with shareholders holding more than 5% shares, actual controllers, other directors, supervisors and senior managers of the company, has not been punished by China Securities Regulatory Commission and other relevant departments and the stock exchange, and has not been punished by the company law, Shenzhen Stock Exchange GEM Listing Rules and other laws, regulations The circumstances stipulated in the normative documents that are not allowed to serve as senior managers of listed companies are not dishonest Executees.
It is hereby announced.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of directors March 24, 2022 Annex:
Resume of Aobo
Ao Bo, male, born in August 1986, bachelor degree, Chinese nationality, without permanent residency abroad, certified public accountant. From February 2012 to may 2015, he served as the project manager of Hubei Branch of Lixin Certified Public Accountants (special general partnership); From June 2015 to December 2019, served as senior manager of Citic Securities Company Limited(600030) South China Co., Ltd; From January 2020 to October 2021, served as Citic Securities Company Limited(600030) senior manager; Started in November 2021 Tibet Duo Rui Pharmaceutical Co.Ltd(301075) .
As of the date of this announcement, Mr. Aobo does not hold shares of the company, has no relationship with shareholders holding more than 5% shares, actual controllers, other directors, supervisors and senior managers of the company, has not been punished by China Securities Regulatory Commission and other relevant departments and the stock exchange, and has not been punished by the company law, Shenzhen Stock Exchange GEM Listing Rules and other laws, regulations The circumstances stipulated in the normative documents that are not allowed to serve as senior managers of listed companies are not dishonest Executees.
